Ambu lowers 2025/2026 organic sales growth guidance to 10 percent

Danish medical technology firm Ambu has revised its organic sales growth forecast for the 2025/2026 fiscal year downward to approximately 10 percent, narrowing the previous 10-12 percent range. The adjustment reflects a shift in growth expectations for the company's medical device portfolio.